Jobs
>
San Francisco

    Associate Director Biostatistics - San Francisco, United States - Proclinical

    Default job background
    Permanent
    Description

    Associate Director Biostatistics - Permanent - Remote

    Proclinical Staffing is seeking an Associate Director Biostatistics to join a cutting-edge pharmaceutical company. This is a permanent role with the opportunity to work remotely.

    Primary Responsibilities

    The Associate Director, Biostatistics is responsible for statistical activities in support of clinical trials, including contributing to trial designs, authoring statistical sections of protocols, preparing statistical analysis plans, and reviewing and interpreting the analysis of clinical trial data.

    Skills & Requirements:

  • Ph.D. in Biostatistics or Statistics or Equivalent with at least 7 years pharmaceutical biostatistics experience; or MS with at least 10 years relevant experience.
  • Excellent written and oral communication and presentation skills.
  • Experience programming in SAS.
  • Interest in and basic understanding of biology and biological processes, including RNAi.
  • Experience in clinical development through Phase 3 (NDA submission).
  • Experience as lead statistician for a compound
  • Understanding of ICH GCP as well as general knowledge of industry practices and standards.
  • Proficiency in R programming language and other statistical software, including EAST.
  • Experience with CDISC, including SDTM, ADaM, CDASH.
  • Experience in representing sponsors in meetings with interaction with US FDA and international regulatory authorities.
  • Experience designing and conducting adaptive trials.The Associate Director Biostatistics will:
  • Represents biostatistics at cross-functional team meetings to drive clinical development of drug candidate and provides input on clinical development plans.
  • Collaborates with Clinical Development, Regulatory and Clinical Operations Expertise Areas to design clinical trials.
  • Writes the statistical sections of clinical trial protocols, while consulting with internal and external experts.
  • Contributes to or prepares statistical analysis plans.
  • Collaborates with Data Management, Clinical Development and Clinical Operations on design of eCRFs.
  • Provides statistical guidance on conduct of ongoing trials.
  • Collaborates with Statistical Programmers on summary and analysis of trial data.
  • Writes ADS and ad hoc analysis specifications.
  • Contributes to clinical study reports and other regulatory documents e.g. DSURs, Briefing Documents, etc.
  • Represents in meetings with regulators, Key Opinion Leaders, partners, and other stakeholders
  • Contributes to scientific articles, summarizing data collected in trials.
  • Participates in other activities and meetings to support Biostatistics and the
  • Development Team as needed.
  • Consults with Research & Preclinical colleagues on statistical questions in their work.
  • Manages CRO statistical and programming support.Compensation:

    $210,000 annually

    If you are having difficulty in applying or if you have any questions, please contact Merna Hermiz at (+1) or

    Proclinical is a specialist employment agency and recruitment business, providing job opportunities within major pharmaceutical, biopharmaceutical, biotechnology and medical device companies.

    Proclinical Staffing is an equal opportunity employer.



  • Vera Therapeutics Brisbane, United States

    Job Description · Title: Director, Biostatistics · Location: Brisbane, CA · About Us: · Vera Therapeutics (Nasdaq: VERA), is a late-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera's mission is to advance treatments that t ...


  • Vera Therapeutics Brisbane, United States

    Job Description · Job DescriptionTitle: Director, Biostatistics · Location: Brisbane, CA · About Us: · Vera Therapeutics (Nasdaq: VERA), is a late-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera's mission is to advance trea ...


  • Vera Therapeutics, Inc. Brisbane, United States

    Title: Director, Biostatistics · Location: · Brisbane, CA · About Us: · Vera Therapeutics (Nasdaq: VERA), is a late-stage biotechnology company focused on developing treatments for serious immunological diseases. Veras mission is to advance treatments that target the source o ...


  • Vera Therapeutics, Inc. Brisbane, United States

    Title: Director, Biostatistics · Location: · Brisbane, CA · About Us: · Vera Therapeutics (Nasdaq: VERA), is a late-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera's mission is to advance treatments that target the source of ...


  • TotalMed Staffing San Francisco, United States

    Salary: $190,000 to $240,000 · On-Site: South San Fran, CA · Maximise your chances of a successful application to this job by ensuring your CV and skills are a good match. · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans w ...


  • TotalMed Staffing San Francisco, United States

    Salary: $190,000 to $240,000 · On-Site: South San Fran, CA · Maximise your chances of a successful application to this job by ensuring your CV and skills are a good match. · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans w ...


  • TotalMed Staffing San Francisco, United States

    Salary: $190,000 to $240,000On-Site: South San Fran, CA · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans with cross-functional drug development teamsOversee all the studies for one compound to ensure the consistency of stati ...


  • ALX Oncology Holdings Inc. South San Francisco, United States

    ALX Oncology is a clinical-stage and patient-focused immuno-oncology company developing therapies that block the CD47 myeloid checkpoint pathway. Our lead candidate, evorpacept (ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding dom ...


  • ALX Oncology Inc. South San Francisco, United States

    ALX Oncology is a clinical-stage and patient-focused immuno-oncology company developing therapies that block the CD47 myeloid checkpoint pathway. Our lead candidate, evorpacept (ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding dom ...


  • Cargo Therapeutics San Carlos, United States

    · The Director, Biostatistics will be responsible for partnering with scientists in Clinical, Safety, Translational Medicine, Regulatory, and Product Development on clinical development projects, development science applications, and/or process/product manufacturing applications ...


  • Cargo Therapeutics San Carlos, United States

    Job Description · Job DescriptionThe Director, Biostatistics will be responsible for partnering with scientists in Clinical, Safety, Translational Medicine, Regulatory, and Product Development on clinical development projects, development science applications, and/or process/prod ...


  • Cargo Therapeutics, Inc. San Carlos, United States

    The Director, Biostatistics will be responsible for partnering with scientists in Clinical, Safety, Translational Medicine, Regulatory, and Product Development on clinical development projects, development science applications, and/or process/product manufacturing applications, a ...


  • Denali Therapeutics South San Francisco, United States

    The Opportunity · Denali Therapeutics is dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine. · Denali Therapeutics is seeking to recruit a highly experienced ...


  • Penfield Search Partners Ltd San Francisco, United States

    Our client is a biotechnology company dedicated to the discovery and development of next-generation cancer treatments. The company has had great success building a clinically differentiated pipeline of small molecules and biotherapeutics, including antibody-drug conjugates, to ta ...


  • TotalMed, Inc. South San Francisco, United States

    Salary: $190,000 to $240,000 · On-Site: South San Fran, CA · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans with cross-functional drug development teams · Oversee all the studies for one compound to ensure the consistency of s ...


  • TotalMed Staffing South San Francisco, United States

    Salary: $190,000 to $240,000 · On-Site: South San Fran, CA · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans with cross-functional drug development teams · Oversee all the studies for one compound to ensure the consistency of ...


  • Kyverna Therapeutics Emeryville, United States

    Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases. The Kyverna therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the a ...


  • Cytokinetics South San Francisco, United States

    Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle p ...


  • TotalMed Staffing South San Francisco, United States

    Salary: $190,000 to $240,000 · On-Site: South San Fran, CA · Responsibilities: · Participate in strategic planning and develop optimal clinical development plans with cross-functional drug development teams · Oversee all the studies for one compound to ensure the consistency ...


  • Cytokinetics, Incorporated South San Francisco, United States

    Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle p ...